SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010887
Filing Date
2019-11-13
Accepted
2019-11-13 07:22:47
Documents
49
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mlnd-20190930x10q.htm 10-Q 2319577
2 EX-10.1 mlnd-20190930ex101c1ede8.htm EX-10.1 105117
3 EX-10.2 mlnd-20190930ex1025bb3d2.htm EX-10.2 90437
4 EX-10.3 mlnd-20190930ex10342b69c.htm EX-10.3 66370
5 EX-31.1 mlnd-20190930ex3111a8f60.htm EX-31.1 11524
6 EX-31.2 mlnd-20190930ex312f31261.htm EX-31.2 11456
7 EX-32.1 mlnd-20190930ex3212dd5c1.htm EX-32.1 10526
  Complete submission text file 0001558370-19-010887.txt   5511577

Data Files

Seq Description Document Type Size
8 EX-101.INS mlnd-20190930.xml EX-101.INS 763721
9 EX-101.SCH mlnd-20190930.xsd EX-101.SCH 26067
10 EX-101.CAL mlnd-20190930_cal.xml EX-101.CAL 44331
11 EX-101.DEF mlnd-20190930_def.xml EX-101.DEF 78430
12 EX-101.LAB mlnd-20190930_lab.xml EX-101.LAB 333054
13 EX-101.PRE mlnd-20190930_pre.xml EX-101.PRE 220408
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 191211678
SIC: 2834 Pharmaceutical Preparations